Advanced Micro Devices, Inc.'s Q4 earnings report revealed strong revenue growth but highlighted concerns about stagnant data center operating margins and limited future growth prospects. Despite significant hype and innovation, AMD's forward P/E ratio requires cautious analysis due to potential risks and compressed margins. AMD's guidance for Q1 2025 indicates limited growth, raising concerns about capitalizing on the current AI and cloud infrastructure investment wave.

CSCO's second-quarter fiscal 2025 performance is likely to reflect improving demand in the networking domain and strong growth in the Security business.

SolarWinds (SWI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Integral Ad Science Holding Corp. (NASDAQ: IAS) between March 2, 2023 and February 27, 2024, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 31, 2025.

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN) of a class action securities lawsuit.

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Nextracker Inc. ("Nextracker" or the "Company") (NASDAQ: NXT) of a class action securities lawsuit.

Lyft is reportedly aiming to bring autonomous robotaxis to its app as soon as next year. The service would launch first in Dallas with additional markets to follow, TechCrunch reported Monday (Feb. 10), citing comments from a company executive.

ENSG's fourth-quarter results gain on strong contribution from the Skilled Services unit, partly offset by the escalating cost of services. It estimates 2025 adjusted EPS to be within $6.16-$6.34.

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Pacira BioSciences, Inc. ("Pacira" or the "Company") (NASDAQ: PCRX) of a class action securities lawsuit.

FirstEnergy line rebuild to benefit 500 West Penn Power customers GREENSBURG, Pa. , Feb. 10, 2025 /PRNewswire/ -- FirstEnergy Pennsylvania Electric Company (FE PA), a subsidiary of FirstEnergy Corp. (NYSE: FE) doing business as West Penn Power in western Pennsylvania, has upgraded its electric system in eastern Westmoreland County to help prevent service disruptions, support voltage and accommodate growth.

Stock Of The Day: Taser maker Axon sees AI-related sales take off and its drone business gain momentum. Axon stock is near a buy point.

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Innovative Industrial Properties, Inc. ("Innovative Industrial Properties" or the "Company") (NYSE: IIPR) of a class action securities lawsuit.

Hims & Hers Health (HIMS) stock moves a notch higher Monday morning after the company's weight-loss drug ad played during the Super Bowl. The commercial's airing raised concerns from health experts and US lawmakers over the exclusion of potential side effects tied to GLP-1 weight-loss treatments in the advertisement.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Liberty Broadband Corp ("LBRDA" or the "Company") (NASDAQ:LBRDA) stock purchased prior to September 22, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Liberty and Charter Communications, Inc. ("Charter"), whether the Board of LBRDA harmed stockholders by agreeing to enter into this transaction, and whether all material facts have been properly disclosed to stockholders.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Innovative Industrial Properties, Inc. (NYSE:IIPR) between February 27, 2024 and December 19, 2024, both dates inclusive (the "Class Period"), of the important March 18, 2025 lead plaintiff deadline. SO WHAT: If you purchased IIPR securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=128469&wire=1 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Innovative Industrial Properties, Inc. (NYSE:IIPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/innovative-industrial-properties-inc-lawsuit-submission-form?prid=128467&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=128468&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Aspen Technology Inc. ("AZPN" or the "Company") (NASDAQ:AZPN) stock purchased prior to January 27, 2025. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Aspen Technology Inc. and Emerson Electric (EMR), whether the Board of AZPN have harmed stockholders by agreeing to enter into this transaction, and whether all material facts have been properly disclosed to stockholders.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own Revance Therapeutics Inc ("RVNC" or the "Company") (NASDAQ:RVNC) Stock purchased prior to August 11, 2024. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of Revance by Crown Laboratories, Inc. ("Crown").